200
Participants
Start Date
February 7, 2024
Primary Completion Date
May 31, 2025
Study Completion Date
December 31, 2025
Early adoption of blood-based biomarkers for Alzheimer's disease
A blood test will be performed to obtain plasma measures of Amyloid-β (Aβ) 42/40, phosphorylated tau (p-tau) 181, p-tau217, p-tau231 and Glial fibrillary acidic protein (GFAP) and Neurofilament light chain (NfL) and results will be disclosure to the early and late arms at different time points.
Hospital del Mar, Barcelona
Hospital del Mar Research Institute (IMIM)
OTHER